Individualizing Treatment Approaches for Epileptic Patients with Glucose Transporter Type1 (GLUT-1) Deficiency
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Individualizing Treatment Approaches for Epileptic Patients with Glucose Transporter Type1 (GLUT-1) Deficiency
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 19, Issue 1, Pages 122
Publisher
MDPI AG
Online
2018-01-08
DOI
10.3390/ijms19010122
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Pharmacogenomics in epilepsy
- (2018) Simona Balestrini et al. NEUROSCIENCE LETTERS
- The role of genetic testing in epilepsy diagnosis and management
- (2017) Yvonne G. Weber et al. EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
- Triheptanoin for the treatment of brain energy deficit: A 14-year experience
- (2017) Fanny Mochel JOURNAL OF NEUROSCIENCE RESEARCH
- The Impact of Next-Generation Sequencing on the Diagnosis and Treatment of Epilepsy in Paediatric Patients
- (2017) Davide Mei et al. Molecular Diagnosis & Therapy
- UX007 for the treatment of long chain-fatty acid oxidation disorders: Safety and efficacy in children and adults following 24 weeks of treatment
- (2017) J. Vockley et al. MOLECULAR GENETICS AND METABOLISM
- Genomics-Guided Precise Anti-Epileptic Drug Development
- (2017) Norman Delanty et al. NEUROCHEMICAL RESEARCH
- Brain microvasculature defects and Glut1 deficiency syndrome averted by early repletion of the glucose transporter-1 protein
- (2017) Maoxue Tang et al. Nature Communications
- A Different SLC2A1 Gene Mutation in Glut 1 Deficiency Syndrome: c.734A>C
- (2017) Rüya Çolak et al. Balkan Medical Journal
- Use of modified Atkins diet in glucose transporter type 1 deficiency syndrome
- (2016) Sofiane Amalou et al. DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY
- Precision medicine in genetic epilepsies: break of dawn?
- (2016) Philipp Sebastian Reif et al. Expert Review of Neurotherapeutics
- Precision medicine
- (2016) Richard Hodson NATURE
- Use of dietary therapies amongst patients with GLUT1 deficiency syndrome
- (2016) Hannah R. Kass et al. SEIZURE-EUROPEAN JOURNAL OF EPILEPSY
- Metabolic syndrome update
- (2016) Scott M. Grundy TRENDS IN CARDIOVASCULAR MEDICINE
- Precision medicine in genetic epilepsies: break of dawn?
- (2016) Philipp Sebastian Reif et al. Expert Review of Neurotherapeutics
- The role ofSLC2A1mutations in myoclonic astatic epilepsy and absence epilepsy, and the estimated frequency of GLUT1 deficiency syndrome
- (2015) Jan Larsen et al. EPILEPSIA
- Do Glut1 (glucose transporter type 1) defects exist in epilepsy patients responding to a ketogenic diet?
- (2015) Felicitas Becker et al. EPILEPSY RESEARCH
- When should clinicians search for GLUT1 deficiency syndrome in childhood generalized epilepsies?
- (2015) Sébastien Lebon et al. EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY
- The pharmacogenomics of epilepsy
- (2015) Valentina Franco et al. Expert Review of Neurotherapeutics
- Personalized medicine approaches in epilepsy
- (2015) L. E. Walker et al. JOURNAL OF INTERNAL MEDICINE
- Triheptanoin dramatically reduces paroxysmal motor disorder in patients with GLUT1 deficiency
- (2015) Fanny Mochel et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Molecular mechanisms of epilepsy
- (2015) Kevin Staley NATURE NEUROSCIENCE
- The pharmacogenomics of epilepsy
- (2015) Valentina Franco et al. Expert Review of Neurotherapeutics
- Dietary Treatments and New Therapeutic Perspective in GLUT1 Deficiency Syndrome
- (2014) Pierangelo Veggiotti et al. Current Treatment Options in Neurology
- Glucose metabolism transporters and epilepsy: Only GLUT1 has an established role
- (2014) Michael S. Hildebrand et al. EPILEPSIA
- Refractory Absence Epilepsy and Glut1 Deficiency Syndrome: A New Case Report and Literature Review
- (2014) Francesca Ragona et al. NEUROPEDIATRICS
- Genetic Biomarkers in Epilepsy
- (2014) Yvonne G. Weber et al. Neurotherapeutics
- Epilepsy, energy deficiency and new therapeutic approaches including diet
- (2014) Christopher A. Reid et al. PHARMACOLOGY & THERAPEUTICS
- Triheptanoin for Glucose Transporter Type I Deficiency (G1D)
- (2014) Juan M. Pascual et al. JAMA Neurology
- The Many Faces of Glut1 Deficiency Syndrome
- (2013) Michal Tzadok et al. JOURNAL OF CHILD NEUROLOGY
- GLUT1 deficiency syndrome 2013: Current state of the art
- (2013) Valentina De Giorgis et al. SEIZURE-EUROPEAN JOURNAL OF EPILEPSY
- Glucose transporter type I deficiency syndrome: Epilepsy phenotypes and outcomes
- (2012) Amanda W. Pong et al. EPILEPSIA
- Triheptanoin reduces seizure susceptibility in a syndrome-specific mouse model of generalized epilepsy
- (2012) Tae Hwan Kim et al. EPILEPSY RESEARCH
- Perampanel—new promise for refractory epilepsy?
- (2012) Wolfgang Löscher et al. Nature Reviews Neurology
- GLUT1 mutations are a rare cause of familial idiopathic generalized epilepsy
- (2012) P. Striano et al. NEUROLOGY
- Energy depletion in seizures: Anaplerosis as a strategy for future therapies
- (2012) Stjepana Kovac et al. NEUROPHARMACOLOGY
- A modified Atkins diet is promising as a treatment for glucose transporter type 1 deficiency syndrome
- (2011) YASUSHI ITO et al. DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY
- Standards for epidemiologic studies and surveillance of epilepsy
- (2011) David J. Thurman et al. EPILEPSIA
- SLC2A1 gene analysis of Japanese patients with glucose transporter 1 deficiency syndrome
- (2011) Natsuko Hashimoto et al. JOURNAL OF HUMAN GENETICS
- Drug-Resistant Epilepsy
- (2011) Patrick Kwan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pharmacogenomics and epilepsy: the road ahead
- (2011) Gianpiero L Cavalleri et al. PHARMACOGENOMICS
- Glucose transporter-1 deficiency syndrome: the expanding clinical and genetic spectrum of a treatable disorder
- (2010) W. G. Leen et al. BRAIN
- Mechanisms of action of antiepileptic drugs: the search for synergy
- (2010) Carl E Stafstrom CURRENT OPINION IN NEUROLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now